IPC Fellow Dr. Yemsrach Abawaji shares her firsthand perspective on the barriers to psoriasis diagnosis and treatment in Ethiopia and opportunities to improve care.
IPC recognizes its 2025 Fellows as IPC Jr. Councilors following the completion of their fellowship. This transition recognizes their contributions to psoriasis research, education, and global collaboration, and marks their expanded role in the IPC network.
A new regional collaboration led by IPC and partner organizations aims to improve diagnosis, treatment, and care coordination for psoriasis and psoriatic arthritis across Latin America.
Discover how the 2025 IPC International Fellows navigated a year of global learning, collaboration, and growth to help advance psoriasis care.
Experts from across five continents discuss regional biosimilar uptake and practical strategies for optimizing psoriasis treatment in this IPC-led symposium at ICD 2025 in Rome.
National cohort data from Taiwan reveal a strong link between immune checkpoint inhibitor (ICI) therapy and new-onset psoriasis in cancer patients, especially in older men. Dermatologists should understand this emerging risk to improve the detection and management of ICI-related skin reactions.
Discover the new free psoriasis course on WHOAcademy, created by IPC and IFPA for the WHO. Enhance your knowledge of psoriasis epidemiology, diagnosis, and management.
The 2024 IPC International Fellows reflect on their global dermatological journey, sharing their unique experiences, challenges, and achievements from a transformative year in advancing psoriasis care.
Uncover the true impact of psoriasis and learn about critical steps to improve diagnosis, treatment, and patient support in the comprehensive Economist Impact white paper supported by Bristol Myers Squibb.
Learn about the new global diagnostic criteria for Generalized Pustular Psoriasis as set by the International Psoriasis Council. Discover the essential features, the importance of accurate diagnosis, and the expected global impact on patient care.
Highlighting a decade of psoriasis advocacy. IPC is pleased to join IFPA in celebrating the 20th anniversary of the World Health Assembly Resolution anniversary; this post uncovers significant strides in psoriasis care, research, and policy advocacy and outlines future directions for global impact.
Join Dr. Mahira Hamdy El Sayed, a dedicated dermatologist, esteemed Professor, and a crucial member of the International Psoriasis Council (IPC). Dr. El Sayed’s story reflects passion, advocacy, and positive change for people with psoriasis worldwide.
IPC Councilor Helen Young provides commentary on a study identifying skin-derived myeloid precursors and CD200+ fibroblasts as key drivers of psoriatic disease spread from the skin to joints, highlighting the CD200–CD200R1 axis as a promising therapeutic target.
IPC Fellow Dr. Yemsrach Abawaji shares her firsthand perspective on the barriers to psoriasis diagnosis and treatment in Ethiopia and opportunities to improve care.
Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.
Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.
